pISSN 1226-4512 eISSN 2093-3827

Article

home Article View

Original Article

Korean J Physiol Pharmacol 2012; 16(1): 71-77

Published online February 29, 2012 https://doi.org/10.4196/kjpp.2012.16.1.71

Copyright © Korean J Physiol Pharmacol.

Defective Mitochondrial Function and Motility Due to Mitofusin 1 Overexpression in Insulin Secreting Cells

Kyu-Sang Park1, Andreas Wiederkehr2, and Claes B. Wollheim3

1Department of Physiology, Institute of Lifestyle Medicine, Yonsei University Wonju College of Medicine, Wonju 220-701, Korea, 2Nestlé Institute of Health Sciences, 1015 Lausanne, 3Department of Cell Physiology and Metabolism, University of Geneva, 1211 Geneva, Switzerland

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Mitochondrial dynamics and distribution is critical for their role in bioenergetics and cell survival. We investigated the consequence of altered fission/fusion on mitochondrial function and motility in INS-1E rat clonal β-cells. Adenoviruses were used to induce doxycycline-dependent expression of wild type (WT-Mfn1) or a dominant negative mitofusin 1 mutant (DN-Mfn1). Mitochondrial morphology and motility were analyzed by monitoring mitochondrially-targeted red fluorescent protein. Adenovirus-driven overexpression of WT-Mfn1 elicited severe aggregation of mitochondria, preventing them from reaching peripheral near plasma membrane areas of the cell. Overexpression of DN-Mfn1 resulted in fragmented mitochondria with widespread cytosolic distribution. WT-Mfn1 overexpression impaired mitochondrial function as glucose- and oligomycin-induced mitochondrial hyperpolarization were markedly reduced. Viability of the INS-1E cells, however, was not affected. Mitochondrial motility was significantly reduced in WT-Mfn1 overexpressing cells. Conversely, fragmented mitochondria in DN-Mfn1 overexpressing cells showed more vigorous movement than mitochondria in control cells. Movement of these mitochondria was also less microtubule-dependent. These results suggest that Mfn1-induced hyperfusion leads to mitochondrial dysfunction and hypomotility, which may explain impaired metabolism-secretion coupling in insulin-releasing cells overexpressing Mfn1.

Keywords: Mitochondrial fusion, Mitofusin 1, Mitochondrial function, Mitochondrial motility, Insulin secretion

The pancreatic β-cell is a specialized metabolic sensor of the body that releases insulin to maintain blood glucose levels in a narrow range. Glucose uptake elicits downstream signals accelerating the exocytosis of insulin granules in β-cell [1]. In this process, generation of ATP and other coupling factors from mitochondria play an important role [2]. Disturbing mitochondrial function in pancreatic β-cells impairs metabolism-secretion coupling and promotes the development of type 2 diabetes [2,3]. Mutations in mitochondrial DNA have been described that result in maternally inherited diabetes [4]. Furthermore, islet β-cells from diabetic patients display mitochondrial dysfunction [5].

Mitochondria are dynamic organelles, which continuously divide and fuse. These processes are mediated by fission and fusion proteins. The two main components of the fission machinery are Fis1 and Drp1 [6]. Drp1 translocates from the cytosol to predetermined fission sites on the mitochondria, and constricts the membrane by a GTPase-dependent mechanism [7]. Fis1 was suggested to recruit Drp1 to the mitochondrial outer membrane [8]. Mitochondrial fission factor has been reported as another Drp1 receptor in the fission process [9,10]. Inhibition of the fission proteins protects against apoptosis [11], but also impairs mitochondrial function by decreasing autophagocytosis [12].

Mitochondrial fusion is mediated by mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2) in the outer membrane as well as Opa1 in the inner mitochondrial membrane [6]. Both Mfn1 and Mfn2 have a GTPase domain in the N-terminus and loss of function mutation in this domain disrupts fusion activity resulting in excessive fission when overexpressed [13]. Deletion of the Mfn1 or Mfn2 genes in the mouse results in mitochondrial dysfunction and embryonic lethality [14]. Mutations in Mfn2 cause a neurological disease affecting sensory and motor peripheral neurons [15].

Mitochondria continuously move in the cytosol, which is required for optimal cell function especially when the amount of the organelles is limiting [16]. This motility enables mitochondria to supply ATP and other metabolites even to distal parts of the cell or allows the organelle to buffer local Ca2+ increases efficiently [17]. Cytoskeletal tracks and several motor proteins responsible for mitochondrial movement have been identified [18]. Kinesin and dynein are involved in antegrade or retrograde movement of mitochondria along microtubules. Milton and Miro act as adaptors localized on mitochondria [17]. Miro is a Rho-GTPase with Ca2+ binding motifs [19]. This protein may mediate Ca2+-induced inhibition of mitochondrial motility in order to recruit active mitochondria to sites of local Ca2+ increase [20]. In pancreatic β-cells, mitochondrial localization and ATP supply to peripheral area might be important, because local rises of the ATP/ADP ratio are most likely required to induce the closure of plasmalemmal KATP channels leading to voltage-sensitive Ca2+ influx and insulin exocytosis [21].

We previously reported that mitochondrial fragmentation does not have a negative impact on mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells [22]. On the other hand, overexpression of wild type mitofusin 1 (WT-Mfn1) evoked hyperfusion of the mitochondria with lowered cellular ATP levels, increased lactate production and impaired insulin release [22]. In this study, we report that WT-Mfn1 overexpression impairs mitochondrial motility and function in INS-1E cells as assessed by live cell confocal imaging and measurement of the mitochondrial membrane potential. These defects were not observed in cells overexpressing dominant negative mutant mitofusin 1 (DN-Mfn1).

Cell culture

INS-1E rat clonal β-cells were cultured in a humidified atmosphere (37℃) containing 5% CO2 in complete medium composed of RPMI 1640 (Invitrogen, Carlsbad, CA, USA) supplemented with 10% FCS (Invitrogen), 1 mM sodium pyruvate, 50 µM 2-mercaptoethanol, 2 mM glutamine, 10 mM HEPES, 100 U/ml penicillin, and 100 µg/ml streptomycin.

Adenovirus infection

Doxycycline-inducible adenoviruses encoding WT-Mfn1 and DN-Mfn1 were constructed as described previously [22]. One day after plating INS-1E cells, adenoviruses encoding the transgene were applied together with the adenovirus expressing the reverse tetracycline-transactivator to INS-1E cells for 90~120 min 1 day after seeding [23]. Before the experiment, cells were cultured for 48 hours with or without doxycycline (500 ng/ml).

Mitochondrial morphology

Mitochondria of INS-1E cells were visualized by transfecting the mitochondrially-targeted red fluorescent protein (mitoRFP) plasmid using lipofectamine 2,000 (Invitrogen) followed by infection with adenoviruses. Mitochondrial morphology was observed 48 hrs after infection and analyzed using a confocal laser-scanning microscope (LSM510meta, Zeiss, Switzerland) after fixation with 4% paraformaldehyde.

Measurement of mitochondrial membrane potential

INS-1E cells were seeded (5×104 cells/well) on black-walled 96 wellplates and infected with adenoviruses. Cells were cultured in medium with or without doxycycline for 48 hours, and then loaded with 500 nM of JC-1 (Invitrogen) in KRBH buffer (2.8 mM glucose) for 30 minutes at 37℃. After washing, JC-1 fluorescence was measured from cells in KRBH buffer using a FlexStation (Molecular Devices Co., Sunnyvale, CA, USA) as described previously [22].

MTT assay

3-(4,5-dimethylhioazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was purchased from Sigma (St. Louis, MO, USA). INS-1E cells seeded on 96-well microtiter plates were infected with different doses (30~120 ifu/cell) of adenovirus coding for WT-Mfn1 and incubated for 48 hours in medium containing 500 ng/ml doxycycline. Cells were further incubated with MTT (100 µg/well), and solubilized with DMSO. Absorbance of each well at 570 nm and 650 nm was measured using an ELISA reader (Molecular Devices Co.). The difference in absorption (A570-A650) was then calculated.

TUNEL assay

The fraction of apoptotic cells over-expressing WT-Mfn1 was determined using the TUNEL assay (In Situ Cell Death Detection Kit, Roche Diagnostics) according to the manufacturer's instructions. All nuclei were stained with DAPI (1 µg/ml for 5 minutes) and data were expressed as the percent of TUNEL positive cells per DAPI-stained cells.

Mitochondrial motility measurement

After transfecting mitoRFP, mitochondrial images were obtained using an inverted microscope (Zeiss, Switzerland) with confocal spinning disk (QLC100, VisiTech, UK). Image series were analyzed by Metamorph software (Universal Imaging, Molecular Devices Co.). The number of moved pixels per second were normalized to total pixels above the threshold (mitochondria) and used to calculate a 'motility index'.

Statistical analysis

Values are given as mean±S.E. p values were obtained by Student's t-test or one-way ANOVA.

INS-1E cells were infected with adenoviruses encoding WT-Mfn1 or DN-Mfn1. Infection with these viruses in combination with reverse tetracycline-transactivator induced doxycycline-dependent expression in INS-1E cells as demonstrated previously [22]. To follow mitochondrial morphology and localization, we transiently transfected INS-1E cells with mitoRFP and plasmalemma-targeted GFP using lipofection. As shown in Fig. 1A, Mitochondria in control non-induced (without doxycycline incubation) cells showed a filamentous pattern of mitochondria distributed from the perinuclear area to the cell periphery. Overexpression of WT-Mfn1 caused aggregation of the mitochondria by promoting the fusion process. The mitochondria in WT-Mfn1-overexpressing cells did not reach the subplasmalemmal area (Fig. 1B). Conversely, DN-Mfn1 with a point mutation in the GTPase domain (T109A) caused fragmented mitochondria, which were distributed throughout the cytosol (Fig. 1C).

To assess mitochondrial function after manipulation of the fission/fusion machinery, we measured mitochondrial membrane potential (Δψm) changes using the fluorescent dye JC-1. This dye permits ratiometric recording of Δψm changes [22]. Glucose induces hyperpolarization of Δψm. Doxycycline (500 ng/ml) induction of WT-Mfn1 attenuated this hyperpolarization (Fig. 2A). Blockage of the F1F0-ATPase by oligomycin is known to elicit hyperpolarizing changes in well-functioning mitochondria [24]. Dysfunctional mitochondria maintain Δψm by reversal of the F1F0-ATPase, resulting in ATP consumption. Oligomycin in such dysfunctional mitochondria causes depolarization. In WT-Mfn1 overexpressing cells, oligomycin (2.5 µg/ml)-induced hyperpolarization of Δψm was strongly decreased when compared to control cells (Fig. 2A).

Mitochondrial aggregation and the depolarization of Δψm may cause cell death. To follow cell viability in cells overexpressing WT-Mfn1, we used the colorimetric MTT assay. The amount of formazan reaction product formed in the MTT assay reflects the mitochondrial enzyme activity, which allows assessing the cell viability. INS-1E cells were infected with increasing concentrations of WT-Mfn1. Even at the highest concentration of adenovirus particles (120 ifu/cell), WT-Mfn1 did not significantly altered cell viability (Fig. 2B). This result also implies that the mitochondrial enzyme activity at least involved in formazan reaction was not affected by WT-Mfn1 overexpression, although there was a functional deterioration of mitochondria. TUNEL assays further demonstrated that apoptosis was not induced by WT-Mfn1 overexpression (Fig. 2C). In contrast, Fis1 overexpression caused apoptotic cell death as reported previously [22].

We analyzed mitochondrial motility from series of confocal images (Fig. 3). Elongated mitochondria of control INS-1E cells displayed worm-like wriggling movements. Compared to control cells, WT-Mfn1 overexpressing cells had less motile, clumped mitochondria. Mitochondrial motion can be quantified by following changes of mitoRed positive areas. Fig. 3D~F are representative illustrations combining two consecutive images (red- and green-colored) after binarization. We measured the moved mitochondrial pixels and expressed as an arbitrary motility index as described in Materials and Methods. Consistent with our qualitative observations, mitochondrial aggregates after WT-Mfn1 overexpression had a much lower motility index than control cells (Fig. 4D). Conversely, fragmented mitochondria in DN-Mfn1 overexpressing cells showed fast random movement like Brownian motion. Microtubule-dependent movement was estimated by the application of nocodazole which interferes with polymerization of microtubules [20]. Nocodazole significantly attenuated the mitochondrial motility in control cells, but showed less inhibition in DN-Mfn1 overexpressing cells (Fig. 4E). FCCP, a mitochondrial uncoupler, elicited a further inhibition of motility maybe due to collapse of Δψm resulting in ATP depletion [25] or cytosolic Ca2+ increase [26]. Mitochondrial motility in WT-Mfn1 overexpressing cells was affected by neither nocodazole, nor FCCP.

Mitochondrial fusion is an essential process. Knockout mice deficient in either Mfn1 or Mfn2 display mid-gestational lethality [14]. In man, mutations in fusion genes can cause neurodegenerative diseases [15]. Fusion may be particularly important as it mediates the mixing of mitochondrial content where healthy mitochondria may be able to complement dysfunctional mitochondria [27]. Mitofusins also are known to have an impact on cell metabolism. Glucose oxidation, oxygen consumption, and mitochondrial membrane potential are lowered by loss of Mfn2 function [28]. Mfn2 tethers the ER to mitochondria, influences ER structure [29], regulates ER calcium homeostasis and store-operated calcium entry [30]. GTPase activity of Mfn1 and Mfn2 is an essential process for the fusion. Mfn1 GTPase activity is much higher than that of Mfn2 [31]. In this study, we overexpressed either wild type or GTPase-deficient Mfn1 and observed pronounced differences in mitochondrial morphology, dynamics, and function in INS-1E cells. Previously, we had demonstrated that WT-Mfn1 overexpression markedly reduced glucose-stimulated insulin secretion in this cell type [22]. The here presented data suggest that impaired metabolism-secretion coupling in WT-Mfn1 overexpressing cells is related to attenuated mitochondrial motility and function.

Hyperfusion of mitochondria due to WT-Mfn1 overexpression reduced glucose- and oligomycin-induced hyperpolarization. The extent to which mitochondria hyperpolarize in response to oligomycin reflects the quantity of functional mitochondria actively synthesizing ATP. Thus, overexpression of WT-Mfn1 increased the amount of dysfunctional mitochondria in the INS-1E cell population. These results explain our previous findings that INS-1E cells overexpressing WT-Mfn1 have reduced cellular ATP levels and enhanced lactate production [22]. One possible mechanism resulting in mitochondrial dysfunction is loss of mitochondrial autophagy (mitophagy) following Mfn1-induced mitochondrial aggregation. Mitophagy acts as a quality control mechanism by degrading dysfunctional mitochondrial fragments. Silencing of Fis1 or overexpression of dominant negative Drp1 deteriorates the ability of mitochondria to undergo mitophagy [12]. Compromised mitophagy causes the accumulation of oxidized mitochondrial proteins, reduces cellular respiration, and decreases glucose-stimulated insulin secretion [12]. Defects in mitophagy due to WT-Mfn1-induced hyperfusion may increase the proportion of dysfunctional mitochondria and therefore lower total mitochondrial activity.

For insulin secretion, mitochondrial movement to the cell periphery may be critical in order to supply ATP close to KATP channels to initiate β-cell electrical activity finally resulting in insulin granule exocytosis. To date, mitochondrial motility has been investigated mainly in neuronal cells which require mitochondria at sites distant from the cell body. We observed that INS-1E cells as well as pancreatic β-cells have tubular networks of filamentous mitochondria distributed throughout the cytosol [22]. In control INS-1E cells, the mitochondria were undergoing continuous wriggling movements and reached near plasma membrane areas of the cytosol. WT-Mfn1 overexpression caused aggregation and marked inhibition of the mitochondrial motility, preventing them from reaching the subplasma membrane areas. These findings are similar to those reported in neural cells with conditional knockout of Drp1 [32].

It has been reported that embryonic fibroblasts of mitofusin knockout mice have spherical highly fragmented mitochondria, which display disorganized random movement [14]. Similarly, mitochondria of INS-1E cells overexpressing DN-Mfn1 showed enhanced motility of fragmented mitochondria reaching even peripheral areas of the cell. In these cells, nocodazole inhibited mitochondrial movements less than in control cells. Overexpression of DN-Mfn1 may disrupt the association of the mitochondria to the microtubule system therefore allow random mitochondrial movement. Following DN-Mfn1 overexpression, mitochondria are more fragmented and possibly more likely to undergo mitophagy. In these cells, we reported that mitochondrial function was not reduced, but even enhanced [22]. Consistently, DN-Mfn1 neither increased apoptosis nor impaired metabolism-secretion coupling in these cells [22]. We suggest that fragmentation of mitochondria at least in some condition is beneficial in order for the cell to cope with various metabolic and/or oxidative stresses.

A large number of studies demonstrated that an imbalance of mitochondrial fission/fusion can secondarily also affect organelle function and motility. The exact roles of the mitochondrial-shaping proteins and their cell-type specific functions remain unclear. This study shows the negative impact of hyperfusion due to Mfn1 overexpression on mitochondrial activity. These defects likely explain impaired metabolism-secretion coupling in insulin-releasing cells overexpressing Mfn1. Further investigations to unravel the factors controlling mitochondrial morphology and motility are needed. This may allow us to identify pathophysiologic mechanisms linked to defects in mitochondrial dynamics and to develop therapeutic approaches.

This study was supported by the Swiss National Foundation and EuroDia (Grant LSHM-CT-2006-518153), a European Community-funded project under framework program 6 (to C.B.W.) and a grant from Korean National Research Foundation (2010-0014617) (to K-.S.P.).
  1. Maechler P, Wollheim CB. Mitochondrial function in normal and diabetic beta-cells. Nature 2001;414:807-812.
    Pubmed
  2. Wiederkehr A, Wollheim CB. Minireview: implication of mitochondria in insulin secretion and action. Endocrinology 2006;147:2643-2649.
    Pubmed
  3. Wiederkehr A, Wollheim CB. Mitochondrial signals drive insulin secretion in the pancreatic β-cell. Mol Cell Endocrinol 2011
  4. Maassen JA, Janssen GM, 't Hart LM. Molecular mechanisms of mitochondrial diabetes (MIDD). Ann Med 2005;37:213-221.
    Pubmed
  5. Del Guerra S, Lupi R, Marselli L, Masini M, Bugliani M, Sbrana S, Torri S, Pollera M, Boggi U, Mosca F, DelPrato S, Marchetti P. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 2005;54:727-735.
    Pubmed
  6. Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol 2007;8:870-879.
    Pubmed
  7. Yoon Y, Pitts KR, McNiven MA. Mammalian dynamin-like protein DLP1 tubulates membranes. Mol Biol Cell 2001;12:2894-2905.
    Pubmed
  8. James DI, Parone PA, Mattenberger Y, Martinou JC. hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem 2003;278:36373-36379.
    Pubmed
  9. Otera H, Mihara K. Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem 2011;149:241-251.
    Pubmed
  10. Otera H, Wang C, Cleland MM, Setoguchi K, Yokota S, Youle RJ, Mihara K. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol 2010;191:1141-1158.
    Pubmed
  11. Lee Y, Jeong SY, Karbowski M, Smith CL, Youle RJ. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 2004;15:5001-5011.
    Pubmed
  12. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 2008;27:433-446.
    Pubmed
  13. Santel A, Frank S, Gaume B, Herrler M, Youle RJ, Fuller MT. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci 2003;116:2763-2774.
    Pubmed
  14. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003;160:189-200.
    Pubmed
  15. Züchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu E, Polyakov AV, Timmerman V, Schröder JM, Vance JM. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004;36:449-451.
    Pubmed
  16. Reynolds IJ, Rintoul GL. Mitochondrial stop and go: signals that regulate organelle movement. Sci STKE 2004;2004:PE46.
    Pubmed
  17. Boldogh IR, Pon LA. Mitochondria on the move. Trends Cell Biol 2007;17:502-510.
    Pubmed
  18. Frederick RL, Shaw JM. Moving mitochondria: establishing distribution of an essential organelle. Traffic 2007;8:1668-1675.
    Pubmed
  19. Russo GJ, Louie K, Wellington A, Macleod GT, Hu F, Panchumarthi S, Zinsmaier KE. Drosophila Miro is required for both anterograde and retrograde axonal mitochondrial transport. J Neurosci 2009;29:5443-5455.
    Pubmed
  20. Yi M, Weaver D, Hajnóczky G. Control of mitochondrial motility and distribution by the calcium signal: a homeostatic circuit. J Cell Biol 2004;167:661-672.
    Pubmed
  21. Wollheim CB. Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in type II diabetes. Diabetologia 2000;43:265-277.
    Pubmed
  22. Park KS, Wiederkehr A, Kirkpatrick C, Mattenberger Y, Martinou JC, Marchetti P, Demaurex N, Wollheim CB. Selective actions of mitochondrial fission/fusion genes on metabolismsecretion coupling in insulin-releasing cells. J Biol Chem 2008;283:33347-33356.
    Pubmed
  23. Brun T, Franklin I, St-Onge L, Biason-Lauber A, Schoenle EJ, Wollheim CB, Gauthier BR. The diabetes-linked transcription factor PAX4 promotes {beta}-cell proliferation and survival in rat and human islets. J Cell Biol 2004;167:1123-1135.
    Pubmed
  24. Irwin WA, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L, Braghetta P, Columbaro M, Volpin D, Bressan GM, Bernardi P, Bonaldo P. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet 2003;35:367-371.
    Pubmed
  25. Brough D, Schell MJ, Irvine RF. Agonist-induced regulation of mitochondrial and endoplasmic reticulum motility. Biochem J 2005;392:291-297.
    Pubmed
  26. Youm JB, Choi SW, Jang CH, Kim HK, Leem CH, Kim N, Han J. A computational model of cytosolic and mitochondrial [ca] in paced rat ventricular myocytes. Korean J Physiol Pharmacol 2011;15:217-239.
    Pubmed
  27. Chen H, Chan DC. Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum Mol Genet 2009;18:R169-R176.
    Pubmed
  28. Pich S, Bach D, Briones P, Liesa M, Camps M, Testar X, Palacín M, Zorzano A. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 2005;14:1405-1415.
    Pubmed
  29. de Brito OM, Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008;456:605-610.
    Pubmed
  30. Singaravelu K, Nelson C, Bakowski D, de Brito OM, Ng SW, Di Capite J, Powell T, Scorrano L, Parekh AB. Mitofusin 2 regulates STIM1 migration from the Ca2+ store to the plasma membrane in cells with depolarized mitochondria. J Biol Chem 2011;286:12189-12201.
    Pubmed
  31. Ishihara N, Eura Y, Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci 2004;117:6535-6546.
    Pubmed
  32. Ishihara N, Nomura M, Jofuku A, Kato H, Suzuki SO, Masuda K, Otera H, Nakanishi Y, Nonaka I, Goto Y, Taguchi N, Morinaga H, Maeda M, Takayanagi R, Yokota S, Mihara K. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol 2009;11:958-966.
    Pubmed